The Influence of Azithromycin on the Biofilm Formation of Pseudomonas aeruginosa in vitro
The DOI matches its Crossref record.
Abstract
The influence of azithromycin on biofilm formation by Pseudomonas aeruginosa, a cause of refractory chronic respiratory tract infection, was investigated. Alginic acid produced by a mucoid strain of P. aeruginosa was quantified by high-performance liquid chromatography from colonies growing on an agar medium. Polysaccharides in the biofilm formed on silicon chips by a nonmucoid strain were determined by a tryptophan reaction. The effect of azithromycin was examined at concentrations below the minimum inhibitory concentration (sub-MIC) for each strain. Azithromycin significantly inhibited the production of alginic acid from the mucoid strain at > or = 1/256 MIC, and the production of exopolysaccharides from the nonmucoid strain at > or = 1/16 MIC. The inhibition of biofilm formation by azithromycin was also observed by scanning electron microscopy. These findings suggest that azithromycin inhibits biofilm formation by P. aeruginosa at concentrations well below the MIC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
The role of antibiotics and antibiotic resistance in nature
Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 687
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
“On the other hand, sub-inhibitory level of the macrolide antibiotic azithromycin was shown to elicit the exactly opposite phenomenon like suppression of the alginate overproduction and biofilm formation in Pseudomonas aeruginosa (Ichimiya et al., 1996).”
BackgroundAntibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
Geisinger, E., & Isberg, R. R. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004691 · Cited by 548
Rasamiravaka, T., Labtani, Q., Duez, P., & El Jaziri, M. (2015) · BioMed Research International · doi:10.1155/2015/759348 · Cited by 546
Antibiotic-Induced Biofilm Formation
Kaplan, J. B. (2011) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000027 · Cited by 397
Moskowitz, S. M., Foster, J. M., Emerson, J., & Burns, J. L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1915-1922.2004 · Cited by 397
Antibiotics as Signal Molecules
Romero, D., Traxler, M. F., López, D., & Kolter, R. (2011) · Chemical Reviews · doi:10.1021/cr2000509 · Cited by 390
Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Høiby, N., & Givskov, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-07 · Cited by 364
Quorum sensing and bacterial biofilms
Dickschat, J. S. (2010) · Natural Product Reports · doi:10.1039/b804469b · Cited by 355
Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal
Landini, P., Antoniani, D., Burgess, J. G., & Nijland, R. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2468-8 · Cited by 335
Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria
Cepas, V., López, Y., Muñoz, E., Rolo, D., Ardanuy, C., Martí, S., Xercavins, M., Horcajada, J. P., Bosch, J., & Soto, S. M. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0027 · Cited by 326
Nalca, Y., Jänsch, L., Bredenbruch, F., Geffers, R., Buer, J., & Häussler, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1680-1688.2006 · Cited by 317
Quenching the quorum sensing system: potential antibacterial drug targets
Kalia, V. C., & Purohit, H. J. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.532479 · Cited by 310
Maintenance Azithromycin Therapy for Bronchiolitis Obliterans Syndrome: Results of a Pilot Study
Gerhardt, S. G., McDyer, J. F., Girgis, R. E., Conte, J. V., Yang, S. C., & Orens, J. B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200212-1424bc · Cited by 306
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P. M., Solis-Moya, A., & Patel, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub4 · Cited by 298
Hoffmann, N., Lee, B., Hentzer, M., Rasmussen, T. B., Song, Z., Johansen, H. K., Givskov, M., & Høiby, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-06 · Cited by 267
Nirwati, H., Sinanjung, K., Fahrunissa, F., Wijaya, F., Napitupulu, S., Hati, V. P., Hakim, M. S., Meliala, A., Aman, A. T., & Nuryastuti, T. (2019) · BMC Proceedings · doi:10.1186/s12919-019-0176-7 · Cited by 260
Azithromycin alters macrophage phenotype
Murphy, B. S., Sundareshan, V., Cory, T. J., Hayes, D., Anstead, M. I., & Feola, D. J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn007 · Cited by 187
Synergie et antagonisme en antibiothérapie
Denes, É., & Hidri, N. (2009) · Antibiotiques · doi:10.1016/j.antib.2009.02.001 · Cited by 12
Metadata
- Authors
- Ichimiya, T., Takeoka, K., Hiramatsu, K., Hirai, K., Yamasaki, T., & Nasu, M.
- Venue
- Chemotherapy
- Publisher
- S. Karger AG
- Published
- 1996
- Volume
- 42
- Issue
- 3
- Pages
- 186-191
- ISSN
- 0009-3157 (ISSN-L)
- 1421-9794
- OpenAlex
- W2095503047
- Cited by
- 157
- References
- 0
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.